AI assistant
Sending…
RESMED INC — Director's Dealing 2025
Feb 11, 2025
30071_dirs_2025-02-11_de16a180-16b2-49d9-9416-7a1617458aaa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2025-02-10
Reporting Person: Sandercock Brett (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-02-10 | ResMed Common Stock | S | 1000 | $238.98 | Disposed | 91864 | Direct |
Footnotes
F1: The transaction was conducted under a Rule 10b5-1 plan adopted February 6, 2024.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29